1. FK506 in clinical kidney transplantation;Shapiro;Transplant Proc,1991
2. Neurotoxicity of FK506 m liver transplant recipients;Frank;Transplant Proc,1993
3. Effects of cyclosporin and FK506 on glucose metabolism;Krentz;Diabetologia,1993
4. Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients;Mor;Transplantation,1994
5. Aj Krentz, J. Dmitrewski, Ad Mayer, M. Nattrass, Metabolic effects of immunosuppressive agents: implications for the development of post-transplant diabetes mellitus, Clin Immunotherapeutics ((in press)).